Aster DM Healthcare’s proposed merger with High quality Care India Ltd (QCIL) has moved nearer to completion, with shareholder approval secured and an outlined scale-up plan that positions the mixed entity amongst India’s largest hospital networks.
The Blackstone-backed merger, which additionally includes TPG, has acquired 96.68% shareholder approval and is predicted to shut within the first quarter of FY27, topic to regulatory clearances, the corporate mentioned on Thursday.
“We’re constructing a scaled and built-in healthcare platform… This positions the platform to grow to be one of many prime three healthcare suppliers in India,” mentioned Dr Azad Moopen, Founder and Chairman of Aster DM Healthcare.
MUST READ: Simply 2% of on a regular basis healthcare is insured in India. Right here’s why
As soon as accomplished, the mixed entity will function greater than 10,600 beds throughout 28 cities, with a further pipeline of round 4,445 beds, offering visibility to exceed 15,500 beds within the close to time period.
At this scale, Aster will compete extra immediately with established chains comparable to Apollo Hospitals and Manipal Hospitals, each of which have constructed nationwide networks by enlargement and acquisitions.
The mixing with QCIL is predicted to strengthen Aster’s presence throughout key markets whereas bettering working leverage and affected person throughput. Progress in higher-value segments comparable to cardiac and oncology, together with enlargement in diagnostics and medical worth journey, is supporting a shift towards a extra specialty-led combine.
The event comes as personal equity-backed hospital platforms step up enlargement, specializing in capability addition, value efficiencies, and wider geographic attain.
Within the March quarter, Aster reported income of ₹1,182 crore, up 18% year-on-year, whereas working EBITDA rose 31% to ₹253 crore. On a mixed proforma foundation, Aster and QCIL reported income of ₹2,361 crore and working EBITDA of ₹517 crore.
